DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. Both the Biologics and Drugs sectors sectors tied for second most common type.
There were three companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Future Pak | Food and Cosmetics | 05/29/2025 | No Action Indicated (NAI) |
| Future Pak, Ltd. | Food and Cosmetics | 05/29/2025 | Voluntary Action Indicated (VAI) |
| Future Pak, Ltd. | Food and Cosmetics | 05/29/2025 | Voluntary Action Indicated (VAI) |
| Michigan Reproductive Medicine | Biologics | 05/13/2025 | No Action Indicated (NAI) |
| PETNET Solutions, Inc. | Drugs | 04/30/2025 | No Action Indicated (NAI) |
Alerts Sign-up